Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

Dopaminergic pathway is the most disrupted pathway in the pathogenesis of Parkinson's disease. Several studies reported associations of dopaminergic genes with the occurrence of adverse events of dopaminergic treatment. However, none of these studies adopted a pathway based approach. The aim of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Pharmacol
Huvudupphovsmän: Redenšek, Sara, Flisar, Dušan, Kojović, Maja, Gregorič Kramberger, Milica, Georgiev, Dejan, Pirtošek, Zvezdan, Trošt, Maja, Dolžan, Vita
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2019
Ämnen:
Pharmacology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360186/
https://ncbi.nlm.nih.gov/pubmed/30745869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00008
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk